ALKBH5 demethylates the m 6 A modification of SOCS3 in microglia/macrophages and alleviates neuroinflammation after brain injury
Open Access
- 23 September 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (39)
Abstract
Microglia/macrophage-induced neuroinflammation plays a crucial role in the progression of traumatic brain injury (TBI). However, the involvement of N6-methyladenosine (m 6 A) RNA modifications in this process remains elusive. Single-cell RNA sequencing (scRNA-seq) and m 6 A RNA immunoprecipitation sequencing (MeRIP-seq) across multiple time points postinjury revealed a strong correlation between m 6 A modifications and genes enriched in microglia/macrophages. Furthermore, the m 6 A demethylase ALKBH5 was identified as a key regulator of dynamic m 6 A patterns at the injury site. ALKBH5 suppression in microglia/macrophages exacerbated neuroinflammation in vitro and worsened neurological deficits in controlled cortical impact (CCI) models. MeRIP-qPCR and RNA pull-down assays revealed SOCS3 was a downstream target of ALKBH5-mediated m 6 A demethylation. This demethylation stabilized Socs3 mRNA and enhanced its protein expression, which in turn suppressed neuroinflammation via inhibiting the JAK2-STAT3 pathway. Conversely, SOCS3 depletion impaired functional recovery after injury. These findings unveiled a critical ALKBH5–m 6 A–SOCS3 regulatory axis that mitigated microglia/macrophage-driven neuroinflammation after TBI, underscoring its potential as a therapeutic intervention target for TBI progression.Keywords
Funding Information
- MOST | National Natural Science Foundation of China (82301557)
- MOST | National Natural Science Foundation of China (82171373)
- MOST | National Natural Science Foundation of China (32170958)
This publication has 50 references indexed in Scilit:
- Unraveling the molecular complexity: Wtap/Ythdf1 and Lcn2 in novel traumatic brain injury secondary injury mechanismsCell Biology and Toxicology, 2024
- The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injuryNeuroscience & Biobehavioral Reviews, 2021
- Drosophila as a model to explore secondary injury cascades after traumatic brain injuryBiomedicine & Pharmacotherapy, 2021
- Traumatic Brain InjuryMedical Clinics of North America, 2020
- Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm ShiftNeuron, 2017
- Transcription Factor NF-κB: An Update on Intervention StrategiesArchivum Immunologiae et Therapiae Experimentalis, 2016
- Microglia in the TBI brain: The good, the bad, and the dysregulatedExperimental Neurology, 2016
- Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcomeBrain, Behavior, and Immunity, 2015
- SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implicationsEuropean Journal of Immunology, 2014
- Inflammation after trauma: Microglial activation and traumatic brain injuryAnnals of Neurology, 2011